CDH13: Cadherin 13 (T-Cadherin) Gene

A comprehensive biomedical overview of CDH13, encoding T-cadherin, with roles in cell adhesion, cancer, and cardiovascular disease.

Gene Information Card

Symbol CDH13
Full Name Cadherin 13
Gene Type Protein coding
Chromosomal Location 16q23.3
NCBI Gene ID 1012 ncbi.nlm.nih.gov/gene/1012
Ensembl ID ENSG00000140945
UniProt ID P55290
OMIM ID 601364
HGNC ID 1753
Aliases T-cadherin, H-cadherin, CDHH, P105

Description

CDH13 encodes T-cadherin, a member of the cadherin superfamily of calcium-dependent cell adhesion molecules. Unlike classical cadherins, T-cadherin lacks a transmembrane domain and is anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) moiety. It is involved in cell-cell adhesion, signaling, and modulation of cell growth. CDH13 is frequently silenced by promoter methylation in various cancers and is associated with cardiovascular traits such as hypertension and coronary artery disease.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Promoter hypermethylation silences CDH13 expression, reducing tumor suppression and promoting invasion. ClinVar, COSMIC
Lung cancer Loss of CDH13 expression via methylation correlates with poor prognosis and metastasis. NCBI Gene, COSMIC
Coronary artery disease Genetic variants in CDH13 are associated with altered plasma adiponectin levels and increased CAD risk. OMIM, ClinVar
Hypertension CDH13 polymorphisms linked to blood pressure regulation through adiponectin signaling. OMIM
Colorectal cancer CDH13 methylation detected in tumor tissues; associated with microsatellite instability. COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Brain 8.3 Low
Lung 15.2 Medium
Liver 2.1 Not detected
Kidney 9.8 Low
Skeletal muscle 6.4 Low
Adipose tissue 18.7 Medium
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 5.2 Low expression; often methylated
A549 (lung cancer) 3.8 Reduced due to promoter methylation
HUVEC (endothelial) 22.1 High expression; vascular role
HEK293 (embryonic kidney) 14.5 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.748C>T (p.Arg250*) Nonsense <0.1% Loss of function; truncated protein
c.1012G>A (p.Gly338Arg) Missense <0.1% Unknown significance
Promoter methylation Epigenetic Common in tumors Silencing of gene expression
Mutation functional classification

Loss of Function (LOF)

Nonsense mutations (e.g., p.Arg250*) and promoter methylation lead to loss of T-cadherin expression, reducing cell adhesion and promoting tumor progression.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in CDH13.

Dominant Negative (DN)

No dominant-negative mutations described for CDH13.

Pathways

Cell adhesion molecules (CAMs) – KEGG hsa04514
Adipocytokine signaling pathway – KEGG hsa04920
Regulation of actin cytoskeleton – KEGG hsa04810

Protein Summary

T-cadherin (UniProt P55290) is a 713-amino-acid GPI-anchored cadherin that mediates calcium-dependent cell adhesion and signaling. It is expressed in endothelial cells, smooth muscle, and neural tissues. The protein lacks a cytoplasmic domain and is involved in modulating cell growth, migration, and survival. Altered expression is linked to cancer and cardiovascular diseases.

Related Products

Product name Cat.No. Species Gene ID
CDH13 Knockout HEK293 Cell Line EDJ-KQ4242 Human 1012 Details Get a Quote
CDH13 Knockout HeLa Cell Line EDJ-KQ26713 Human 1012 Details Get a Quote
CDH13 Knockout A-549 Cell Line EDJ-KQ61326 Human 1012 Details Get a Quote
CDH13 Knockout HCT 116 Cell Line EDJ-KQ69824 Human 1012 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: